Literature DB >> 8570317

A radiologic update on medical diseases of the newborn chest.

R H Cleveland1.   

Abstract

This paper reviews the common spectrum of medical diseases of the neonatal chest. Emphasis is on radiographic changes that have been produced by the introduction of new therapeutic maneuvers, particularly the use of artificial surfactant in treating hyaline membrane disease and the survival of profoundly premature newborns (less than 650 g). A discussion of meconium aspiration syndrome, neonatal pneumonia, transient tachypnea of the newborn, congenital lymphangiectasia, and congenital heart disease is also included. The effects on the neonatal chest radiograph of extracorporeal membrane oxygenation and high-frequency ventilation are also mentioned.

Entities:  

Mesh:

Year:  1995        PMID: 8570317     DOI: 10.1007/bf02011835

Source DB:  PubMed          Journal:  Pediatr Radiol        ISSN: 0301-0449


  15 in total

1.  American Academy of Pediatrics Committee on Fetus and Newborn: Surfactant replacement therapy for respiratory distress syndrome.

Authors: 
Journal:  Pediatrics       Date:  1991-06       Impact factor: 7.124

Review 2.  Chlamydial infections (second of three parts).

Authors:  J Schachter
Journal:  N Engl J Med       Date:  1978-03-02       Impact factor: 91.245

Review 3.  Chlamydial infections (first of three parts).

Authors:  J Schachter
Journal:  N Engl J Med       Date:  1978-02-23       Impact factor: 91.245

Review 4.  Chlamydial infections (third of three parts).

Authors:  J Schachter
Journal:  N Engl J Med       Date:  1978-03-09       Impact factor: 91.245

5.  Pulmonary disease following respirator therapy of hyaline-membrane disease. Bronchopulmonary dysplasia.

Authors:  W H Northway; R C Rosan; D Y Porter
Journal:  N Engl J Med       Date:  1967-02-16       Impact factor: 91.245

6.  Effects of exogenous surfactant therapy on dynamic compliance during mechanical breathing in preterm infants with hyaline membrane disease.

Authors:  R J Couser; T B Ferrara; J Ebert; R E Hoekstra; J J Fangman
Journal:  J Pediatr       Date:  1990-01       Impact factor: 4.406

7.  Bubbles in hyaline membrane disease. Differentiation of three types.

Authors:  L E Swischuk
Journal:  Radiology       Date:  1977-02       Impact factor: 11.105

8.  Effect of high-frequency ventilation on the development of alveolar edema in premature monkeys at risk for hyaline membrane disease.

Authors:  J C Jackson; W E Truog; T A Standaert; S E Juul; J H Murphy; E Y Chi; A P Mackenzie; W A Hodson
Journal:  Am Rev Respir Dis       Date:  1991-04

9.  Radiographic findings in early onset neonatal group b streptococcal septicemia.

Authors:  J C Leonidas; R T Hall; E C Beatty; R A Fellows
Journal:  Pediatrics       Date:  1977-06       Impact factor: 7.124

10.  Retained fetal lung liquid in congenital lobar emphysema: a possible predictor of polyalveolar lobe.

Authors:  R H Cleveland; B Weber
Journal:  Pediatr Radiol       Date:  1993
View more
  4 in total

1.  Evaluation of surfactant function at birth determined by the stable microbubble test in term and near term infants with respiratory distress.

Authors:  Humberto H Fiori; Roseli Henn; Matteo Baldisserotto; Igor G O Bica; Renato M Fiori
Journal:  Eur J Pediatr       Date:  2004-06-08       Impact factor: 3.183

2.  Incidence, Clinical Features, and Outcomes of Transient Tachypnea of the Newborn at a Tertiary Care Center in Western India.

Authors:  Sanajay Chavan; Sudhir D Malwade; Soni Kumari; Balakrushna P Garud; Sharad Agarkhedkar
Journal:  Cureus       Date:  2022-04-07

Review 3.  Clinical Approach to a Neonate with Cyanosis.

Authors:  Saurabh Kumar Gupta
Journal:  Indian J Pediatr       Date:  2015-09-19       Impact factor: 1.967

4.  Calving duration and obstetric assistance influence pulmonary function of Holstein calves during immediate fetal-to-neonatal transition.

Authors:  Camila Infantosi Vannucchi; Liege Cristina Garcia Silva; Silvana Maria Unruh; Cristina Fátima Lúcio; Gisele Almeida Lima Veiga
Journal:  PLoS One       Date:  2018-09-18       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.